Prescription drug · ANDA
Betamethasone dipropionate NDC 68180-947
Betamethasone dipropionate .5 mg/g · Ointment, Augmented · Topical · Lupin Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68180-947-01 | 68180094701 | 1 TUBE in 1 CARTON (68180-947-01) / 15 g in 1 TUBEMarketed from Mar 19, 2020 | |
| 68180-947-02 | 68180094702 | 1 TUBE in 1 CARTON (68180-947-02) / 50 g in 1 TUBEMarketed from Mar 19, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Betamethasone dipropionate
- Generic name (nonproprietary)
- betamethasone dipropionate
- Active ingredients
- Betamethasone dipropionate — .5 mg/g
- Dosage form
- Ointment, Augmented
- Route
- Topical
- Labeler
- Lupin Pharmaceuticals, Inc.NDC labeler code 68180
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209106
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 68180-947_fb870496-75f5-4f2a-a156-2552d9c13e7fSPL ID fb870496-75f5-4f2a-a156-2552d9c13e7fSPL set ID 216d5b7f-4236-4882-b899-be17cb1a1584RxCUI 848180UNII 826Y60901UUPC 0368180947028
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468180094701followed by a unit qualifier and the quantityPackage 68180-0947-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Betamethasone dipropionate ointment USP (augmented) is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older. Betamethasone dipropionate ointment USP (augmented) is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age and older. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 68180-947
- What is NDC 68180-947?
- 68180-947 is the product NDC for Betamethasone dipropionate, Betamethasone dipropionate .5 mg/g ointment, augmented, listed with the FDA by Lupin Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Betamethasone dipropionate.
- What is the active ingredient?
- Betamethasone dipropionate.
- Who is the labeler?
- Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Betamethasone dipropionate?
- 54 other product NDCs are listed under this name. See all Betamethasone dipropionate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Betamethasone dipropionate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | CreamTopical | Aurobindo Pharma Limited | 59651-891 | 59651-0891-1459651-0891-46 |
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/mL | Lotion, AugmentedTopical | Encube Ethicals, Inc. | 21922-104 | 21922-0104-0121922-0104-21 |
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | Ointment, AugmentedTopical | Burel Pharmaceuticals, LLC | 35573-107 | 35573-0107-1535573-0107-49 |
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | CreamTopical | REMEDYREPACK INC. | 70518-4187 | 70518-4187-00 |
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | Ointment, AugmentedTopical | Aurobindo Pharma Limited | 59651-699 | 59651-0699-1459651-0699-4659651-0699-50 |
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | OintmentTopical | Padagis Israel Pharmaceuticals Ltd | 45802-505 | 45802-0505-1445802-0505-84 |
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | OintmentTopical | Bryant Ranch Prepack | 63629-9323 | 63629-9323-01 |
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | OintmentTopical | Bryant Ranch Prepack | 63629-9324 | 63629-9324-01 |
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | OintmentTopical | Bryant Ranch Prepack | 71335-2715 | 71335-2715-01 |
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | OintmentTopical | Bryant Ranch Prepack | 72162-1415 | 72162-1415-0272162-1415-04 |
Other NDCs under ANDA 209106
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Betamethasone dipropionate | Betamethasone dipropionate .5 mg/g | Ointment, AugmentedTopical | A-S Medication Solutions | 50090-6787 |